Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.220
-0.030 (-2.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
814,985
Open
1.270
Bid (Size)
1.230 (8)
Ask (Size)
1.290 (3)
Prev. Close
1.250
Today's Range
1.200 - 1.285
52wk Range
1.025 - 2.850
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD
August 15, 2024
This article highlights the 4 largest market cap clinical-stage psychedelic compound-based drug discovery companies with their stock performances MTD, in July, their areas of focus, and their latest...
Via
Talk Markets
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Atai Life Sciences reports positive early data for its DMT-based depression treatment, VLS-01, and plans a Phase II trial targeting treatment-resistant patients.
Via
Benzinga
Performance
YTD
-27.81%
-27.81%
1 Month
-23.75%
-23.75%
3 Month
-28.65%
-28.65%
6 Month
-33.70%
-33.70%
1 Year
-23.27%
-23.27%
More News
Read More
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
August 13, 2024
Via
InvestorPlace
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
August 13, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 07, 2024
From
atai Life Sciences
Via
GlobeNewswire
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Via
Benzinga
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
July 14, 2024
Via
Talk Markets
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
Via
InvestorPlace
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
July 08, 2024
Via
InvestorPlace
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
Via
InvestorPlace
Exposures
Product Safety
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
July 03, 2024
Via
InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
Via
InvestorPlace
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
Via
Talk Markets
atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
June 26, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Via
Talk Markets
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
June 20, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
June 09, 2024
Via
Talk Markets
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
Via
Benzinga
Exposures
Product Safety
What's Going On With MindMed And Psychedelic Stocks?
June 05, 2024
Via
Benzinga
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
May 31, 2024
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
May 23, 2024
From
atai Life Sciences
Via
GlobeNewswire
ATAI Stock Earnings: ATAI Life Sciences Beats EPS for Q1 2024
May 15, 2024
Via
InvestorPlace
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
May 15, 2024
From
atai Life Sciences
Via
GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.